Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
“This is really the thing we look forward to all year and we weren’t going to let the pandemic get in the way this year,” said DCI exec. director Michael Kastan, MD, PhD.
Join faculty speakers from the DCI Hematologic Malignancies & Cellular Therapy Disease Group on Oct. 5 for a virtual OncLive summit on leukemia & lymphoma.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Harry Erba, MD, PhD, David Rizzieri, MD, and Thomas LeBlanc, MD, discuss the benefits of therapy for the great majority of older acute myeloid leukemia patients.